Article: Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology and Vascular Medicine.
VASA. Zeitschrift fur Gefasskrankheiten
2024 Volume 53, Issue 2, Page(s) 109–119
Abstract: Cilostazol is a quinolinone-derivative selective phosphodiesterase inhibitor and is a platelet-aggregation inhibitor and arterial vasodilator for the symptomatic treatment of intermittent claudication (IC). Cilostazol has been shown to improve walking ... ...
Abstract | Cilostazol is a quinolinone-derivative selective phosphodiesterase inhibitor and is a platelet-aggregation inhibitor and arterial vasodilator for the symptomatic treatment of intermittent claudication (IC). Cilostazol has been shown to improve walking distance for patients with moderate to severe disabling intermittent claudication who do not respond to exercise therapy and who are not candidates for vascular surgical or endovascular procedures. Several studies evaluated the pharmacological effects of cilostazol for restenosis prevention and indicated a possible effect on re-endothelialization mediated by hepatocyte growth factor and endothelial precursor cells, as well as inhibiting smooth muscle cell proliferation and leukocyte adhesion to endothelium, thereby exerting an anti-inflammatory effect. These effects may suggest a potential effectiveness of cilostazol in preventing restenosis and promoting the long-term outcome of revascularization interventions. This review aimed to point out the role of cilostazol in treating patients with peripheral arterial disease, particularly with IC, and to explore its possible role in restenosis after lower limb revascularization. |
---|---|
MeSH term(s) | Humans ; Cilostazol/adverse effects ; Intermittent Claudication/diagnosis ; Intermittent Claudication/drug therapy ; Tetrazoles ; Vasodilator Agents/adverse effects ; Peripheral Arterial Disease/diagnosis ; Peripheral Arterial Disease/drug therapy ; Cardiology ; Italy |
Chemical Substances | Cilostazol (N7Z035406B) ; Tetrazoles ; Vasodilator Agents |
Language | English |
Publishing date | 2024-03-01 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 120977-2 |
ISSN | 1664-2872 ; 0301-1526 |
ISSN (online) | 1664-2872 |
ISSN | 0301-1526 |
DOI | 10.1024/0301-1526/a001114 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 808: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.